• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Cannabis

The Cannabis Sector and Its Dot-Com Like Meltdown

Black-market vaping has made the entire cannabis group toxic.
By TIMOTHY COLLINS
Sep 30, 2019 | 03:30 PM EDT
Stocks quotes in this article: MO

The unintended consequence in the slow-moving argument around cannabis and CBD legalization is the rise in lung illnesses and deaths among vapers. I have been a supporter of the cannabis and CBD market and many companies within them, but with the rising risks of black-market vaping, the entire sector has become toxic.

The irony is these are the companies doing "wrong." I'm not defending Juul here or even Altria (MO) . A company that makes a Fruity Pebbles-flavored alt-nicotine vape product isn't targeting adults. Let's be honest here.

And, yes, there are personal feelings involved in this topic. While I believe cannabis, hemp, and cannabinoids have a ton of potential positive uses, I'm not a fan of vaping, regulated or not. The taking of anything directly into the lungs that isn't medically prescribed and fully tested scares me.

I understand the upside that smoking/vaping provides in terms of measured delivery and quick uptake/effectiveness, but as alternative delivery methods continue to improve, that gap is closing.

The biggest problem I see is the government. We are not only talking about the government dragging its feet on approval and subsequent regulation but also now financing and taxation.

Cannabis and cannabis-related companies are faced with a high cost of capital to do business. That cost of capital is eventually passed through to the consumer. Additionally, companies pay an enormous amount in taxes. Again, this is passed through to the consumer if the business wants to remain in business.

Unfortunately, some users are looking for the lowest cost, which pushes them to the black market. Some users don't have legal access, which pushes them to the black market.

And the black market sells products with the largest "profit" margins looking to stretch every dollar because of the heightened risk, which pushes some sellers to the use of untested and potentially dangerous substances.

We are not seeing deaths from regulated products in regulated markets. We are seeing deaths, in my view, as a result government entities afraid to act for fear of seeing deaths or epidemic usage growing out of control. The irony is by not acting because of their fears, their fears are coming to fruition.

From the rubble will rise some fantastic opportunities in quality names, but the cannabis sector drubbing right now is reminiscent of the dot-com blowup. With depressed stock prices and valuations falling in the private market, we are going to see some names vanish or bought at a cheap price for fear they won't get through this vaping disaster.

More government is seldom the answer, but no government or one turning a blind eye can be even worse.

I know a few subs have asked me about specific names and their poor performance as of late, but what we are seeing now is not company-specific weakness. This action is what we call "throwing out the baby with the bathwater." Everything is being sold whether the underlying company performance is strong or weak.

If you don't have patience or you've been buying every name because cannabis 2.0 will reignite the sector this month, then the road may be rough until the black-market vaping issue is directly addressed.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Collins had no positions in any securities mentioned.

TAGS: Mergers and Acquisitions | Regulation | Investing | Trading | Marijuana | Tobacco | Cannabis

More from Cannabis

What's Up With the SPAC Silver Spike Acquisition?

Bruce Kamich
Jan 22, 2021 9:58 AM EST

WM Holdings, a cloud software provider for the cannabis industry, will soon be coming public by a reverse merger with SSPK.

My 'Aggressive', Under-the-Radar Stock Pick for 2021

Timothy Collins
Jan 21, 2021 12:15 PM EST

This cannabis-related model that sheds the commodity moniker and actually is a life sciences company.

Cannabis Leader Canopy Growth Can Climb Higher

Bruce Kamich
Jan 20, 2021 9:32 AM EST

Here's how to play CGC.

KushCo Sprinkles Some Gems on Its Earnings Call

Debra Borchardt
Jan 17, 2021 8:15 AM EST

The cannabis packaging company is looking at Arizona and New Jersey as new markets for growth.

I'm Coming Back Around to LiDAR Related Names

Timothy Collins
Jan 13, 2021 1:01 PM EST

Three stocks top my list for plays: Velodyne Lidar, Luminar Technologies, and Collective Growth Crop.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    I'll discuss price targets in my Saturday column.
  • 07:54 AM EST GARY BERMAN

    Friday Morning Fibocall for 1/22/2021

    SPX (Long-Term View) The 1/21/21 NEW high @ 3861...
  • 11:16 AM EST CHRIS VERSACE

    Worst Stocks to Buy for the Biden Presidency

    Biden's take on the minimum wage, likely moves on ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login